BACKGROUND
Most evidence for transcatheter aortic valve replacement (TAVR) for valve-in-valve procedures comes from balloon-expandable and supra-annular self-expanding valves. However, data on intra-annular self-expanding valves remain limited. The objectives of this registry were to evaluate the short- and midterm out...
Jorge F. Chavez, G. Tirado-Conte, Y. Kobari et al.· Journal of the American Hear...· 0 citations
BACKGROUND
Data on the long-term incidence and clinical impact of bioprosthetic valve failure (BVF) after transcatheter aortic valve replacement remain limited. This study aimed to assess the incidence, predictors, and clinical impact of BVF following transcatheter aortic valve replacement.
METHODS
We analyzed data f...
A. Trimaille, P. Cepas-Guillén, M. Urena et al.· Circulation. Cardiovascular...· 0 citations
TTVR with the LuX-Valve Plus system to treat patients with severe or greater symptomatic TR and a large tricuspid annulus was associated with high intraprocedural and 30-day clinical success rates, significant TR reduction and functional improvement, and low permanent pacemaker implantation rates.
O. de Backer, Y. Lim, R. von Bardeleben et al.· EuroIntervention· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.